Back to ARCT overview

ARCT Arcturus Therapeutics Holdings PE ratio, current and historical analysis

The current PE ratio of ARCT can't be determined, as the TTM EPS of -$1.12 is negative. The last PE ratio of Arcturus Therapeutics Holdings, recorded in September 2023, was 6.8.

ARCT PE ratio history

How has ARCT's PE ratio performed in the past

Average

N/A

Median

N/A

Minimum

N/A

Maximum

N/A

Arcturus Therapeutics Holdings PE ratio by year

Year	PE ratio	Change
2023	N/A	N/A
2022	48.46	N/A
2021	N/A	N/A
2020	N/A	N/A
2019	N/A	N/A
2018	N/A	N/A
2017	N/A	N/A
2016	N/A	N/A
2015	N/A	N/A
2014	N/A	N/A

ARCT average PE ratio chart

What is the average PE ratio of ARCT for the past years

3-year avg

N/A

5-year avg

N/A

10-year avg

N/A

15-year avg

N/A

ARCT PE vs peers

What is ARCT's PE ratio compared to its peers

Stock name	PE ratio	Market cap
NWBO Northwest Biotherapeutics Inc	N/A	$547.39M
ARCT Arcturus Therapeutics Holdings Inc	N/A	$751.2M

Frequently asked questions

What is Arcturus Therapeutics Holdings's PE ratio?

The current price to earnings ratio of ARCT can't be calculated, as its EPS of -$1.12 is negative.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.